2024 , Vol. 21 >Issue 10: 972 - 977
DOI: https://doi.org/10.3877/cma.j.issn.1672-6448.2024.10.007
品管圈在提高甲状腺结节细针穿刺检出率中的应用
Copy editor: 汪荣
收稿日期: 2024-07-01
网络出版日期: 2024-12-23
基金资助
宁波市医学重点学科建设项目资助(2022-X11)
版权
Application of quality control circles in improving detection rate of thyroid nodules by fine-needle aspiration
Received date: 2024-07-01
Online published: 2024-12-23
Copyright
目的
探讨品管圈活动在提高超声引导下甲状腺结节细针穿刺活检检出率中的应用效果。
方法
宁波市鄞州区第二医院超声科于2023年5月至2023年10月开展以“提高甲状腺结节细针穿刺活检检出率”为主题的品管圈活动。收集2023年5月15日至2023年5月26日50例甲状腺结节细针穿刺活检患者的资料(对7个观察点进行查验,共计查验350个观察点),分析影响超声引导下甲状腺结节细针穿刺活检检出率的主要原因,确定真因,讨论并制定相应对策,实施拟定对策;收集2023年9月18日至9月29日50例甲状腺结节细针穿刺活检患者的资料进行效果确认,计算不合格率、目标达成率和进步率,标准化持续实施。收集品管圈实施前(2023年4月1日至4月30日)和品管圈实施后(2023年11月1日至11月30日)1个月内甲状腺结节细针穿刺患者资料,计算甲状腺结节细针穿刺检出率,采用χ2检验比较品管圈活动前后甲状腺结节穿刺检出率的差异。并收集分析2023年12月至2024年4月每个月的甲状腺结节穿刺检出率。
结果
对策实施后(2023年9月18日至9月29日),不合格率由对策实施前的16.9%(59/350)降至5.71%(20/350),目标达成率为118.1%,进步率达66.1%。品管圈实施后1个月甲状腺结节穿刺检出率为93.1%(121/130),品管圈实施前1个月甲状腺结节穿刺检出率为81.6%(93/114),实施后检出率高于实施前,差异具有统计学意义(χ2=7.446,P=0.006)。2023年12月至2024年4月每个月的甲状腺结节穿刺检出率分别为94.2%、92.7%、94.9%、93.2%、92.8%。
结论
通过开展品管圈活动规范甲状腺结节细针穿刺活检操作流程,可有效提高甲状腺结节细针穿刺活检检出率,值得推广借鉴。
罗辉 , 方晔 . 品管圈在提高甲状腺结节细针穿刺检出率中的应用[J]. 中华医学超声杂志(电子版), 2024 , 21(10) : 972 -977 . DOI: 10.3877/cma.j.issn.1672-6448.2024.10.007
Objective
To explore the application of the quality control circle activity in improving the detection rate of thyroid nodules by fine-needle aspiration under the guidance of ultrasound.
Methods
From May to October 2023, the Ultrasound Department of No. 2 Hospital of Yinzhou District, Ningbo City, launched a quality control circle activity with the theme of “increasing the detection of thyroid nodules by fine-needle aspiration”.The information of 50 patients who underwent fine-needle aspiration of thyroid nodules from May 15 to 26,2023 (examination of 7 observation points per case, with a total of 350 observation points) to analyze the factors influencing the detection rate by fine-needle aspiration under ultrasound guidance. Corresponding countermeasures were then formulated and implemented, and 50 cases of thyroid nodules undergoing fine-needle aspiration from September 18 to 29, 2023 were tested for the non-conformity rate, the rate of goal achievement, and the rate of improvement, and the quality control circle activity continued to be implemented. Before (April 1 to 30, 2023)and after the implementation of the quality control circle activity (November 1 to 30, 2023), the information of patients who underwent fine-needle aspiration of thyroid nodules Was collected to calculate the detection rate of thyroid nodule by fine-needle aspiration, and the χ2 test was used to compare the difference in the detection rate between before and after the implementation of the quality control circle activity. The thyroid gland nodules were punctured every month from December 2023 to April 2024.
Results
After the implementation of the quality control circle activity (September 18 to 29, 2023), the non-conformity rate decreased from 16.9% (59/350) before the implementation to 5.71% (20/350), the rate of goal achievement was 118.1%, and the rate of improvement was 66.1%. Thyroid gland nodules were detected in 93.1% (121/130) of the patients after the implementation of quality control circle activity. The positive rate of thyroid gland nodules was 81.6% (93/114) before the implementation of quality control circle activity. The positive rate after implementation of quality control circle activity was significantly higher than that before implementation (χ2=7.446,P=0.006). The detection rate of thyroid modules by fine-needle aspiration was 94.2%, 92.7%, 94.9%, 93.2%, and 92.8%, respectively, from December 2023 to April 2024.
Conclusion
The implementation of quality control circle activity can effectively improve the detection rate of thyroid nodules by fine-needle aspiration, which is worthy promotion.
1 |
Puga MF, Ferreira IP, BrandãoJR, et al. Comparison of cytological adequacy between 23- and 25-gauge in ultrasound-guided fine-needle aspiration of thyroid nodules: a single-center prospective study [J].Acta Cytol, 2024, 68(2): 121-127.
|
2 |
上海市医学会超声医学分会介入学组, 上海市社会医疗机构协会超声医学分会介入与重症超声专业委员会. 超声引导下甲状腺结节细针穿刺细胞学检查实践指南(2019版)[J]. 中华超声影像学杂志, 2020, 29(5): 369-383.
|
3 |
Watts NB, Camacho PM, Lewiecki EM, et al. American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update [J]. Endocr Pract, 2021, 27(4): 379-380.
|
4 |
Cai XJ, Valiyaparambath N, Nixon P, et al. Ultrasound-guided fine needle aspiration cytology in the diagnosis and management of thyroid nodules [J]. Cytopathology, 2006, 17(5): 251-256.
|
5 |
梁爽, 陈梦杰, 万锦秀, 等. 多模态超声对提高甲状腺结节细针穿刺活检取材成功率的价值[J/OL]. 中华医学超声杂志(电子版),2021, 18(10): 998-1004.
|
6 |
方晔, 谢晓红, 罗辉. 品管圈在提高前列腺癌穿刺检出率中的应用[J/OL]. 中华医学超声杂志(电子版), 2023, 20(7): 722-727.
|
7 |
郭黎, 黎骋, 陈昶, 等. 甲状腺细针穿刺液基细胞学与传统细胞涂片的临床应用价值对比分析[J]. 黑龙江医药科学, 2024, 47(2):150-151, 154.
|
8 |
甲状腺细针穿刺细胞病理学诊断专家共识编写组, 中华医学会病理学分会细胞病理学组. 甲状腺细针穿刺细胞病理学诊断专家共识(2023版)[J]. 中华病理学杂志, 2023, 52(5): 441-446.
|
9 |
张晓芳, 刘志艳. 2018版甲状腺细针穿刺活检细胞病理学Bethesda报告系统解读[J]. 中华病理学杂志, 2018, 47(9): 729-732.
|
10 |
Hoang JK, Middleton WD, Langer JE, et al. Comparison of thyroid risk categorization systems and fine needle aspiration recommendations in a multi-institutional thyroid ultrasound registry[J]. J Am Coll Radiol, 2021,18(12): 1605-1613.
|
11 |
Jin X, Lew M, Pantanowitz L, et al. Performance of Afirma genomic sequencing classifier and histopathological outcome in Bethesda category III thyroid nodules: Initial versus repeat fine-needle aspiration[J]. Diagn Cytopathol, 2023, 51(11): 698-704.
|
12 |
Cibas ES, Ali SZ. The 2017 Bethesda system for reporting thyroid cytopathology[J]. Thyroid, 2017, 27(11): 1341-1346.
|
13 |
Hess JR, Van Tassel DC, Runyan CE, et al. Performance of ACR TIRADS and the Bethesda system in predicting risk of malignancy in thyroid nodules at a large children's hospital and a comprehensive review of the pediatric literature [J]. Cancers(Basel), 2023, 15(15): 3975.
|
14 |
陆爱美, 马苏亚, 谢晓红, 等. 品管圈在肝声触诊弹性成像标准化改进中的应用效果[J/OL]. 中华医学超声杂志(电子版), 2022,19(7): 633-638.
|
15 |
谢晓红, 马苏亚, 杜祖升, 等. 县区级超声质量控制管理体系建设的探索[J/OL]. 中华医学超声杂志(电子版), 2020, 17(7): 672-678.
|
/
〈 |
|
〉 |